A few standouts for me come from Nan's statement at the end:
"I am delighted by the strong endorsement our sales team is receiving from medical doctors seeking Australian products."
"Notably our maiden shipment of dried flower exported to Germany sold out in under two weeks. This robust pipeline of new opportunities reflects the
market's confidence in our competitively priced, high-quality GMP-certified products."
“As a result of the B2C initiatives, the increase in exports and the addition product available for sale, we are anticipating strong revenue growth in the next quarter.”
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-27
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.19M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.8¢ | $14.67K | 815.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2271629 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 108109 | 1 |
View Market Depth
| Last trade - 14.44pm 27/09/2024 (20 minute delay) ? |
| ECS (ASX) Chart |